BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/21/2025 2:43:16 PM | Browse: 3 | Download: 0
Category |
Transplantation |
Manuscript Type |
Retrospective Study |
Article Title |
Serum factor V and arterial lactate levels predict graft survival in liver transplant recipients with aminotransferase above five thousand
|
Manuscript Source |
Invited Manuscript |
All Author List |
Gabriel Lazzarotto-da-Silva, Bruno Marches Chaves, Flávia Heinz Feier, Pablo Duarte Rodrigues, Tomaz Jesus Maria Grezzana-Filho, Alexandre de Araujo, Mario Reis Alvares-da-Silva, Roberta Cabral Marchiori, Marcio Fernandes Chedid and Cleber Rosito Pinto Kruel |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Financiamento e Incentivo à Pesquisa of Hospital de Clínicas de Porto Alegre |
No. 170271 |
|
Corresponding Author |
Marcio Fernandes Chedid, MD, PhD, Professor, Liver Transplant and Hepatobiliary Surgery Unit, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos, 2350, Porto Alegre 90035-007, Rio Grande do Sul, Brazil. mchedid@hcpa.edu.br |
Key Words |
Aminotransferase; Liver transplantation; Early allograft failure; Factor V; Lactate |
Core Tip |
Among 341 liver transplant recipients, 25 had an aminotransferase level > 5000 U/L. Early allograft failure (death or re-transplantation within 90 days) occurred in 11 patients. One-year and five-year graft survival rates were 51.7% and 42.6%, respectively. However, approximately 50% of these patients withstood initial graft injury and had a satisfactory long-term prognosis. Therefore, early identification of patients who will recover graft function or undergo graft loss is paramount. Serum factor V and arterial lactate levels can aid in deciding whether to relist patients to retransplantation early in the postoperative period. |
Citation |
Lazzarotto-da-Silva G, Chaves BM, Feier FH, Rodrigues PD, Grezzana-Filho TJM, de Araujo A, Alvares-da-Silva MR, Marchiori RC, Chedid MF, Kruel CRP. Serum factor V and arterial lactate levels predict graft survival in liver transplant recipients with aminotransferase above five thousand. World J Transplant 2025; In press |
 |
Received |
|
2025-03-24 09:33 |
 |
Peer-Review Started |
|
2025-03-24 09:33 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-04-01 05:55 |
 |
Revised |
|
2025-04-13 13:28 |
 |
Second Decision |
|
2025-05-21 02:51 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-05-21 14:43 |
 |
Articles in Press |
|
2025-05-21 14:43 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
2220-3230 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345